Special Senses & Otolaryngology

Orbital and preseptal cellulitis: distinction and management

Clinical Overview and When to Suspect Orbital vs Preseptal Cellulitis

— Preseptal: infection limited to eyelid and periocular skin

— Orbital: infection deep to the septum with risk of vision loss, cavernous sinus thrombosis, and intracranial extension

— Preseptal: usually from local trauma, insect bites, hordeolum, dacryocystitis, conjunctivitis, or impetigo; pathogens are Staphylococcus aureus (including MRSA) and Streptococcus pyogenes

— Orbital: >90% arise from contiguous bacterial sinusitis, especially ethmoid sinusitis in children; polymicrobial (S. aureus, streptococci, anaerobes, H. influenzae in unvaccinated)

— Preseptal: more common overall, peaks in children <5

— Orbital: median age ~7–12 years, M>F, winter peak coinciding with sinusitis

Step 3 management: In the ED, the first triage question is "Is the septum crossed?" If yes (proptosis, painful EOM, vision change), obtain contrast CT of the orbits and sinuses, start IV vancomycin + ceftriaxone (± metronidazole), and consult ophthalmology and ENT immediately—admit. If no, most preseptal cases can be treated with oral antibiotics and close outpatient follow-up.

Anatomic framework — the orbital septum is a fibrous extension of the periosteum into the eyelids; it is the critical barrier separating preseptal (periorbital) infection of the anterior eyelid soft tissue from orbital (postseptal) infection involving fat, extraocular muscles, and structures posterior to the septum.

Epidemiology and source

When to suspect orbital cellulitis — any patient with periocular swelling PLUS one or more of: pain with eye movement, proptosis, ophthalmoplegia, diplopia, decreased visual acuity, or chemosis. These features are not present in preseptal disease.

Why this matters on Step 3 — misclassifying orbital as preseptal delays imaging, IV antibiotics, and ophthalmology/ENT consultation, risking permanent vision loss within hours.

Demographics

Red-flag history clues — recent URI or sinusitis, dental infection, orbital trauma, immunocompromise (especially diabetes → consider mucormycosis), or recent ocular surgery.

Presentation Patterns and Key History

— Child or adult with unilateral eyelid erythema, warmth, swelling, and tenderness developing over 1–3 days after a stye, insect bite, scratch, conjunctivitis, or minor trauma

— Eye itself looks normal once you pry the lid open: normal vision, normal pupils, normal EOMs, no proptosis, no pain with gaze

— Low-grade or no fever; systemic toxicity uncommon

— Often a child age 7–12 with antecedent ethmoid or pansinusitis, presenting with eyelid edema PLUS proptosis, diplopia, painful or restricted eye movements, and decreased visual acuity

— Fever, leukocytosis, and looking sick are typical

— May report dental pain (maxillary source) or recent facial trauma/insect bite

— Onset and rate of progression (orbital evolves faster)

— Recent sinusitis, URI, dental work, orbital trauma, or surgery

— Vaccination status (Hib, pneumococcal) — unvaccinated children at higher risk for H. influenzae and invasive disease

— Immunocompromise: diabetes (especially DKA), neutropenia, transplant, HIV, chronic steroids → broaden differential to mucormycosis and aspergillosis

— Contact lens use, prior MRSA infection, IV drug use

— Tick or insect exposure, allergic conjunctivitis history (helps rule out non-infectious mimics)

— Preseptal: superficial skin tenderness only

— Orbital: deep retro-orbital ache worsened by eye movement — a near-pathognomonic discriminator on history alone

— Any complaint of blurry vision, double vision, or color desaturation mandates postseptal workup until proven otherwise

Key distinction: Pain with eye movement and diplopia are the two highest-yield historical features that flip the diagnosis from preseptal to orbital — ask about them explicitly in every periocular swelling stem. If a question lists either, the answer involves CT orbits and IV antibiotics, not oral cephalexin.

Preseptal cellulitis classic stem

Orbital cellulitis classic stem

Targeted history to obtain in ED

Pain character

Visual symptoms

Physical Exam Findings and Bedside Assessment

— Vitals: orbital cellulitis often febrile (>38.5°C) and tachycardic; preseptal usually afebrile or low-grade

— Toxic appearance + altered mental status → suspect cavernous sinus thrombosis or intracranial extension

— Both: eyelid erythema, warmth, edema, sometimes fluctuance if abscess

— Proptosis (best seen from above looking down at the brow line) — orbital only

— Chemosis (bulbar conjunctival edema) — orbital

— Lid eversion: rule out foreign body, hordeolum, chalazion

— Visual acuity each eye separately with Snellen or near card

— Pupils: check for relative afferent pupillary defect (RAPD) → suggests optic nerve compromise

— Color vision (red desaturation) — early optic neuropathy sign

— Extraocular movements: pain or restriction = postseptal

— Confrontation visual fields

Board pearl: The five cardinal signs of postseptal disease to memorize: (1) proptosis, (2) pain with EOM, (3) ophthalmoplegia, (4) decreased visual acuity, (5) chemosis. Any one of these in a patient with periocular swelling = treat as orbital cellulitis, image, admit, and consult — do not wait for "all five." Missing this on exam is the dominant test-writing trap.

General assessment

Inspection

Visual function exam — do this on every patient

Intraocular pressure — elevated IOP can occur with orbital congestion; measure if proptosis present

Fundoscopy — look for disc edema or venous engorgement suggesting elevated orbital/intracranial pressure

Cranial nerves — CN III, IV, V1/V2, VI all traverse the cavernous sinus; bilateral findings or multiple CN palsies = cavernous sinus thrombosis

Sinus and dental exam — percuss maxillary and frontal sinuses, inspect dentition and gingiva for source

Skin exam — look for adjacent impetigo, abscess, or insect bite as preseptal source

Neuro exam — meningismus, focal deficits → intracranial extension

Diagnostic Workup — Initial Labs and Imaging

— Uncomplicated preseptal cellulitis in a non-toxic, afebrile adult or cooperative child with a clear local source (stye, insect bite) and normal eye exam → no imaging required; clinical diagnosis, treat empirically

— Any concern for orbital cellulitis, inability to assess the eye (severe edema, young child), failure of oral therapy at 24–48h, or systemic toxicity → image

— CBC with differential: leukocytosis with left shift more common in orbital

— Blood cultures × 2 before antibiotics in febrile or admitted patients (yield ~30% in orbital disease)

— BMP, glucose — especially in diabetics; check for DKA which predisposes to mucormycosis

— CRP/ESR: baseline for response tracking

— Coagulation studies if cavernous sinus thrombosis suspected

— Wound or abscess Gram stain and culture if drainable material available

— Lactate if sepsis criteria met

— Indication: suspected orbital cellulitis or unclear exam

— Findings: fat stranding posterior to the septum, extraocular muscle enlargement, subperiosteal abscess (rim-enhancing collection along the lamina papyracea), proptosis, opacified ethmoid/maxillary sinuses

— Subperiosteal abscess location: medial wall most common (ethmoid source)

— Preferred when cavernous sinus thrombosis, intracranial abscess, or optic nerve involvement suspected

— Also preferred in pregnant patients to limit radiation, and to evaluate suspected fungal invasion

CCS pearl: In the CCS simulator for orbital cellulitis, the high-yield order set is: CBC, blood cultures × 2, BMP, lactate, CT orbits/sinuses with contrast, IV vancomycin, IV ceftriaxone, ophthalmology consult, ENT consult, admit. Order imaging and antibiotics in parallel — do not delay antibiotics for the scan.

When labs/imaging are needed

Laboratory studies

First-line imaging — CT orbits and sinuses with IV contrast, thin cuts

MRI orbits and brain with contrast

Avoid plain films — low yield and not standard of care

Diagnostic Workup — Advanced and Confirmatory Studies

— Gold standard for cavernous sinus thrombosis

— Triggers: bilateral eye findings, multiple cranial neuropathies (III, IV, V1/V2, VI), worsening despite appropriate antibiotics, altered mental status, severe headache

— Findings: filling defect in cavernous sinus, dilated superior ophthalmic vein, sinus wall enhancement

— Indicated if meningitis or encephalitis suspected after neuroimaging excludes mass effect

— Coordinate with neurology

— Material from subperiosteal abscess drainage or endoscopic sinus surgery yields the most reliable pathogen identification

— Send for aerobic, anaerobic, fungal, and AFB stains/cultures in immunocompromised patients

— Diabetic with DKA, neutropenic, transplant, or hematologic malignancy patient with periorbital infection → urgent ENT nasal endoscopy with biopsy to evaluate for mucormycosis (black eschar on turbinate, necrotic tissue)

— Histopathology: broad, ribbon-like, non-septate hyphae with right-angle branching

— Aspergillus: septate hyphae with acute-angle branching

— Send fungal cultures and tissue PCR; consider serum beta-D-glucan and galactomannan

— Visual evoked potentials if optic neuropathy uncertain

— B-scan ultrasound when CT is contraindicated and MRI unavailable

— Repeat formal visual acuity, color vision, and IOP every 4 hours during inpatient stay

— Atypical presentations, recurrent disease, or fungal organisms warrant CD4/HIV testing and immunoglobulin levels

Board pearl: Bilateral orbital findings in a patient with sinusitis = cavernous sinus thrombosis until proven otherwise — get MRV, start broad-spectrum antibiotics that cross the blood-brain barrier (ceftriaxone + vancomycin + metronidazole), and anticoagulate (heparin) in consultation with neurology/neurosurgery despite the hemorrhage risk; the mortality benefit outweighs bleeding risk in most cases.

MR venography (MRV)

Lumbar puncture

Operative cultures

Fungal evaluation in high-risk hosts

Ophthalmologic ancillary testing

HIV testing and immune workup

Dental panoramic imaging — if odontogenic source suspected (maxillary tooth abscess)

Risk Stratification and Management Logic

— Group I: Preseptal (periorbital) cellulitis — anterior to septum

— Group II: Orbital cellulitis — diffuse postseptal inflammation without abscess

— Group III: Subperiosteal abscess — pus between periosteum and orbital bone

— Group IV: Orbital abscess — discrete intraorbital pus collection

— Group V: Cavernous sinus thrombosis — intracranial extension

— Group I (preseptal): usually outpatient oral antibiotics in well-appearing adults and children >1 year with reliable follow-up; admit if <1 year, toxic, immunocompromised, unable to assess eye, or failed outpatient therapy

— Groups II–V: admit, IV antibiotics, ophthalmology + ENT consult, serial eye exams every 4 hours

— Large subperiosteal or orbital abscess (>10 mm)

— Decreased visual acuity or RAPD

— No clinical improvement within 24–48 hours of IV antibiotics

— Worsening proptosis, ophthalmoplegia, or pain

— Frontal sinus involvement (risk of Pott puffy tumor and intracranial extension)

— Age >9 years (subperiosteal abscesses in older children/adults are more often polymicrobial and less likely to respond to antibiotics alone)

Step 3 management: The two clinical triggers that should move you from "medical management" to "OR now" are (1) any drop in visual acuity or new RAPD and (2) lack of improvement within 24–48 hours of appropriate IV antibiotics. Document serial visual acuity in the chart every 4 hours — this is both standard of care and medico-legally protective.

Chandler classification of orbital infections (memorize the order — questions love this)

Disposition by Chandler stage

Indications for surgical drainage (ENT/ophtho call)

Conservative (medical) management of small subperiosteal abscess is reasonable if: child <9, small abscess (<10 mm), medial location, no visual compromise, no intracranial extension — with strict serial reassessment

Sepsis pathway — if SIRS/septic shock criteria met, follow Surviving Sepsis bundle: lactate, blood cultures, broad-spectrum antibiotics within 1 hour, 30 mL/kg crystalloid for hypotension or lactate ≥4.

Pharmacotherapy — First-Line Antibiotic Regimens

— Clindamycin 300–450 mg PO TID (covers MRSA, strep, anaerobes) — preferred monotherapy

— Alternative: TMP-SMX DS BID + amoxicillin-clavulanate 875/125 mg BID (TMP-SMX alone misses group A strep)

— Duration: 7–10 days; reassess at 24–48 hours

— If low MRSA risk and no purulence: amoxicillin-clavulanate monotherapy acceptable

— IV ampicillin-sulbactam 3 g q6h, OR

— IV vancomycin + ceftriaxone if MRSA risk or systemic toxicity

— Transition to oral once afebrile 24–48h and improving

— Vancomycin 15–20 mg/kg IV q8–12h (target trough 15–20 or AUC 400–600) — covers MRSA

— PLUS Ceftriaxone 2 g IV q12–24h — covers strep, H. influenzae, most gram-negatives, CNS penetration

— PLUS Metronidazole 500 mg IV q8h if intracranial extension, dental source, or chronic sinusitis suspected (anaerobic coverage)

— Alternative β-lactam: ampicillin-sulbactam 3 g IV q6h or piperacillin-tazobactam 4.5 g IV q6h (covers anaerobes — can omit metronidazole)

— Severe: vancomycin + levofloxacin + metronidazole (or moxifloxacin alone for anaerobes + gram-positives + atypicals)

— Non-severe: cefotaxime/ceftriaxone usually tolerated

— Liposomal amphotericin B 5–10 mg/kg/day IV immediately + urgent surgical debridement + reverse immunosuppression/correct DKA

— Add isavuconazole or posaconazole as step-down

— IV until clinical improvement (typically 5–7 days), then oral to complete total 2–3 weeks (3–4 weeks if subperiosteal/orbital abscess, longer with osteomyelitis or intracranial extension)

Board pearl: Always add MRSA coverage (vancomycin) empirically for orbital cellulitis until cultures return — community MRSA rates make ceftriaxone monotherapy inadequate. De-escalate based on susceptibilities.

Preseptal cellulitis — outpatient (mild, non-toxic, >1 year old, reliable follow-up)

Preseptal cellulitis — inpatient or severe

Orbital cellulitis — empiric IV regimen (admit all)

Penicillin allergy

Suspected mucormycosis

Duration of therapy for orbital cellulitis

Procedures and Surgical Management

— Large subperiosteal abscess (>10 mm diameter or >1.25 mL volume)

— Orbital abscess (Chandler IV)

— Visual compromise: decreased acuity, RAPD, or worsening optic nerve function

— Failure of medical therapy at 24–48 hours

— Intracranial complications (epidural/subdural empyema, brain abscess)

— Frontal sinusitis with Pott puffy tumor

— Suspected fungal infection requiring tissue diagnosis and debridement

— Age >9 (older patients tolerate medical management less reliably)

— Functional endoscopic sinus surgery (FESS) — drains the source sinusitis; first-line in most pediatric subperiosteal abscesses from ethmoid disease

— Transcaruncular or transcutaneous orbital drainage — for medial subperiosteal abscess not adequately drained endoscopically

— External orbitotomy — for lateral, superior, or large posterior abscesses

— Lateral canthotomy and cantholysis — emergent decompression for orbital compartment syndrome (acute proptosis + IOP >40 mmHg + vision loss) — performed at bedside in ED; releases inferior crus of lateral canthal tendon

— Nasal decongestants (oxymetazoline) to facilitate sinus drainage

— Saline nasal irrigation

— Head-of-bed elevation 30° to reduce orbital edema

— Warm compresses (preseptal) or cool compresses (orbital)

— Pain control (avoid NSAIDs if surgery imminent)

— Therapeutic-dose heparin is favored in most expert guidelines despite limited RCT data — reduces mortality and morbidity

— Continue 4–6 weeks or longer; bridge to warfarin or DOAC per neurology

— Controversial; some evidence supports adjunctive IV dexamethasone after 24–48 hours of antibiotics to reduce inflammation in pediatric orbital cellulitis once infection controlled — not standard, use only per specialist guidance

CCS pearl: For orbital compartment syndrome, the test-favored intervention is lateral canthotomy and cantholysis at bedside — do not wait for ophthalmology if vision is being lost. This is a sight-saving procedure within the emergency physician's scope.

Indications for surgical intervention

Surgical procedures

Adjunctive measures

Anticoagulation for cavernous sinus thrombosis

Role of corticosteroids

Special Populations — Elderly and Renal/Hepatic Impairment

— Higher risk of diabetes, vasculopathy, and immunosenescence → atypical/severe presentations

— Lower threshold for imaging and admission even with apparent preseptal disease

— Polymicrobial and gram-negative organisms more common; broaden empiric coverage

— Consider temporal arteritis in any elderly patient with periocular pain, headache, jaw claudication, and elevated ESR — check ESR/CRP and start high-dose steroids before biopsy

— Increased risk of delirium, falls, and pressure injury during admission — implement geriatric bundles

— Vancomycin: dose by weight, monitor trough or AUC; in CKD stage 4–5 or dialysis, give loading dose then dose by levels

— Ceftriaxone: no renal adjustment (biliary excretion) — drug of choice in renal failure

— Piperacillin-tazobactam: reduce dose in CrCl <40

— Ampicillin-sulbactam: reduce in CrCl <30

— TMP-SMX: avoid or reduce; risk of hyperkalemia and AKI, especially with ACEi/ARB/spironolactone

— Aminoglycosides: avoid if possible; use trough-based dosing if necessary

— Liposomal amphotericin B: monitor creatinine daily, replete K and Mg aggressively

— Ceftriaxone: caution in severe hepatic + renal dysfunction (dose cap); avoid in neonates with hyperbilirubinemia

— Metronidazole: reduce dose 50% in severe hepatic dysfunction (Child-Pugh C)

— Clindamycin: hepatically metabolized — monitor LFTs; usually no dose change

— Linezolid: hepatic and bone marrow toxicity, limit to 14 days when possible

— Avoid fluoroquinolones with concurrent QT-prolonging agents

— Glycemic control essential — hyperglycemia impairs neutrophil function

— Screen aggressively for mucormycosis, especially with DKA

— Hold metformin during acute illness/contrast imaging if eGFR borderline

Step 3 management: Any diabetic with periorbital infection and DKA, or a neutropenic patient with periorbital findings, gets emergent ENT nasal endoscopy to rule out mucormycosis — do not assume bacterial cellulitis. Empiric liposomal amphotericin B should be started while awaiting biopsy if clinical suspicion is high.

Elderly patients

Renal impairment

Hepatic impairment

Diabetes mellitus

Special Populations — Pediatrics and Pregnancy

— Most common age for orbital cellulitis: 7–12 years; preseptal more common <5

— Underlying ethmoid sinusitis is the dominant source — thin lamina papyracea allows easy spread

— Vaccination status critical: Hib and pneumococcal conjugate vaccines have dramatically reduced H. influenzae type b orbital infections — unvaccinated children remain at risk

— Children <1 year with preseptal cellulitis: admit, blood cultures, IV antibiotics, consider LP (occult bacteremia/meningitis risk)

— Younger children (<9) with small medial subperiosteal abscess often respond to medical management alone — surgery reserved for failure or vision change

— Watch for non-accidental trauma when injury history is inconsistent

— Ceftriaxone 50–75 mg/kg/day IV (max 2 g)

— Vancomycin 15 mg/kg IV q6h (max 1 g/dose initially)

— Ampicillin-sulbactam 200–300 mg/kg/day divided q6h

— Clindamycin (outpatient preseptal) 30 mg/kg/day divided TID

— Safe antibiotics: ceftriaxone, ampicillin-sulbactam, clindamycin, vancomycin — all category B or preferred

— Avoid: tetracyclines (teeth/bone), fluoroquinolones (cartilage concerns), TMP-SMX in 1st trimester (neural tube) and near term (kernicterus), metronidazole generally acceptable after 1st trimester (use if anaerobic coverage essential)

— Imaging: prefer MRI orbits/brain without gadolinium during pregnancy; CT with contrast acceptable if MRI unavailable and clinically indicated — fetal radiation from head CT is minimal

— Anticoagulation for cavernous sinus thrombosis: LMWH (does not cross placenta), avoid warfarin and DOACs

— Most beta-lactams, clindamycin, and vancomycin compatible

— Limit fluoroquinolones and tetracyclines

— Oncology, transplant, primary immunodeficiency → broader empiric coverage including antifungals; lower threshold for ICU admission

Key distinction: A febrile child <1 year with periorbital swelling deserves full sepsis workup including blood cultures and consideration of LP — do not treat as simple preseptal cellulitis even if the eye exam looks reassuring, because occult bacteremia and meningitis can coexist.

Pediatric considerations

Pediatric antibiotic dosing

Pregnancy

Lactation

Immunocompromised pediatric patients

Complications and Adverse Outcomes

— Optic neuropathy from compression or ischemia → permanent vision loss; heralded by RAPD, decreased acuity, red desaturation

— Central retinal artery or vein occlusion from elevated orbital pressure

— Exposure keratopathy from severe proptosis preventing lid closure → corneal ulceration; treat with lubrication and tarsorrhaphy if needed

— Orbital compartment syndrome — surgical emergency requiring lateral canthotomy

— Cavernous sinus thrombosis — bilateral eye findings, multiple cranial neuropathies (III, IV, V1, V2, VI), septic appearance; mortality 20–30%

— Subdural or epidural empyema

— Brain abscess — frontal lobe most common (frontal sinusitis spread)

— Meningitis

— Superior sagittal sinus thrombosis

— Osteomyelitis of orbital walls or frontal bone — extended antibiotic course (4–6 weeks)

— Pott puffy tumor — frontal bone osteomyelitis with subperiosteal abscess overlying forehead; classic complication of frontal sinusitis in adolescents; requires neurosurgical/ENT drainage

— Sepsis, septic shock, ARDS

— Endocarditis from bacteremic seeding (rare)

— Persistent diplopia from extraocular muscle scarring

— Lacrimal duct stenosis from ethmoid surgery

— Cosmetic deformity post-drainage

— Recurrent sinusitis

— Vancomycin: AKI, ototoxicity, infusion reaction

— Ceftriaxone: biliary pseudolithiasis, C. difficile

— Long-course antibiotics: candidiasis, gut dysbiosis

— Amphotericin: nephrotoxicity, electrolyte derangements

— Growth disturbance from orbital scarring or bone resection

— Learning impact from prolonged hospitalization

Board pearl: A patient with orbital cellulitis who develops bilateral proptosis, bilateral CN VI palsy, or worsening despite appropriate IV antibiotics has cavernous sinus thrombosis until proven otherwise — order MRV emergently, escalate antibiotics to cross the blood-brain barrier (high-dose ceftriaxone + vancomycin + metronidazole), and start therapeutic anticoagulation in consultation with neurology.

Vision-threatening complications

Intracranial complications (5–10% of orbital cellulitis)

Bony complications

Systemic complications

Long-term sequelae

Medication-related adverse events

Pediatric-specific

When to Escalate Care — ICU, Consults, and Triage

— Any postseptal (orbital) cellulitis — Chandler II or higher

— Preseptal cellulitis in infants <1 year, toxic appearance, immunocompromise, failed outpatient therapy, or unreliable follow-up

— Inability to perform an adequate eye exam due to swelling

— Need for IV antibiotics or imaging

— Septic shock or vasopressor requirement

— Cavernous sinus thrombosis or other intracranial extension

— Airway compromise (deep neck space involvement, severe facial swelling)

— Altered mental status, seizures, focal neurologic deficits

— Rapidly progressive vision loss

— Suspected or confirmed mucormycosis

— Postoperative monitoring after extensive orbital/sinus surgery

— Ophthalmology: all orbital cellulitis at presentation; serial visual acuity exams every 4 hours; surgical drainage of orbital abscess

— ENT/Otolaryngology: orbital cellulitis with sinusitis; subperiosteal or orbital abscess drainage; suspected fungal disease for nasal endoscopy and biopsy

— Neurosurgery: intracranial abscess, Pott puffy tumor, frontal lobe involvement

— Infectious disease: immunocompromised host, atypical organisms, prolonged or complicated course

— Neurology + Hematology: cavernous sinus thrombosis (anticoagulation decision)

— Pediatrics/PICU: all pediatric orbital cellulitis admitted

— If your facility lacks pediatric ophthalmology, ENT with FESS capability, or neurosurgery, transfer early rather than wait for deterioration

— Stabilize first: IV access, antibiotics started, airway secured, imaging if time permits

— Visual acuity, pupils, EOMs, proptosis: q4h while inpatient

— Vital signs per ward protocol; sepsis screening

— Reassess clinical response at 24–48 hours — failure to improve triggers reimaging and surgical consultation

CCS pearl: When advancing the simulated clock in CCS, the most commonly missed orders are serial eye exams, repeat CRP/CBC at 48 hours, and re-imaging if no clinical improvement. Schedule these proactively rather than reactively to maximize the case score.

Admit all of the following

ICU admission criteria

Consult services — and when to call

Transfer considerations

Repeat assessment cadence

Key Differentials — Same-Category Infectious Causes

— Acute focal lid lesion at lash line (external) or tarsal plate (internal); tender pustule

— Treatment: warm compresses, lid hygiene; topical antibiotic if drainage; oral antibiotics only if surrounding cellulitis

— Chronic, non-tender granuloma of meibomian gland; not infectious in active sense

— Treatment: warm compresses, intralesional steroid, incision/curettage if persistent

— Infection of the lacrimal sac at medial canthus; warm, tender, erythematous nodule below medial canthus; pus expressed with pressure

— Pathogens: S. aureus, S. pneumoniae

— Treatment: oral or IV antibiotics + warm compresses; dacryocystorhinostomy after acute infection resolves

— Lacrimal gland infection in superotemporal lid; "S-shaped" lid deformity

— Often viral (mumps, EBV) in children; bacterial in adults

— Inflammation of lacrimal canaliculus, often Actinomyces israelii — yellow "sulfur granules" on expression

— Treatment: canaliculotomy + topical penicillin

— Diffuse conjunctival injection, discharge, no proptosis or vision change; lids may be mildly edematous but not the dominant finding

— Adenoviral most common; bacterial responds to topical antibiotics

— Infection inside the globe; severe pain, vision loss, hypopyon; usually post-surgical or post-traumatic

— Treatment: intravitreal antibiotics + vitrectomy

— Facial pressure, purulent rhinorrhea, no proptosis or eye signs

— Most viral; bacterial if symptoms >10 days, worsening after improvement, or severe

— Rapid spread, pain out of proportion, bullae, crepitus, systemic toxicity

— Group A strep or polymicrobial; emergent surgical debridement + IV antibiotics

Key distinction: Dacryocystitis is tender at the medial canthus below the lid, hordeolum is at the lid margin, dacryoadenitis is at the superotemporal lid (S-shape) — anatomic localization on exam distinguishes these from preseptal cellulitis, which is diffuse across the lid.

Hordeolum (stye)

Chalazion

Dacryocystitis

Dacryoadenitis

Canaliculitis

Conjunctivitis (bacterial or viral)

Endophthalmitis

Sinusitis without orbital extension

Necrotizing fasciitis of the face/periorbital region

Key Differentials — Non-Infectious Mimics

— Bilateral, itchy rather than painful, no fever, no tenderness to deep palpation

— Triggers: cosmetics, eye drops, poison ivy, ACE inhibitors

— Treatment: antihistamines, topical/oral steroids, allergen avoidance; epinephrine if airway involved

— May progress to secondary preseptal cellulitis; initially shows central punctum and pruritus

— Treatment: ice, antihistamines; antibiotics if true cellulitis develops

— Bilateral proptosis, lid retraction, lid lag, restrictive ophthalmopathy without fever or acute pain

— Imaging: enlarged extraocular muscles sparing tendon insertions

— Labs: TSH suppressed, TRAb/TSI elevated

— Treatment: smoking cessation, selenium, IV methylprednisolone, teprotumumab, orbital decompression

— Painful proptosis, ophthalmoplegia mimicking orbital cellulitis but no infectious source, no fever, no leukocytosis

— Imaging: muscle enlargement including tendons (distinguishes from Graves)

— Treatment: high-dose corticosteroids — dramatic response is diagnostic

— Rhabdomyosarcoma in children (most common pediatric orbital malignancy) — rapid proptosis without infection signs

— Lymphoma, metastases, optic nerve glioma, meningioma in adults

— Imaging shows mass lesion; biopsy diagnostic

— Pulsatile proptosis, orbital bruit, dilated conjunctival vessels ("corkscrew vessels")

— Diagnosis: CT/MR angiography or catheter angiography

— Post-traumatic; non-infectious; CT shows non-enhancing collection

— Expansile cystic lesion eroding into orbit; painless proptosis, displaces globe

— Sharply demarcated, raised, fiery red plaque; group A strep; responds rapidly to penicillin

Board pearl: Bilateral painless proptosis with lid lag and a suppressed TSH = Graves orbitopathy, not infection — no antibiotics needed. Bilateral painful proptosis with fever and rapid neurologic decline = cavernous sinus thrombosis, the catastrophic infectious mimic. The presence or absence of fever and pain quickly sorts these on the boards.

Allergic contact dermatitis / angioedema

Insect bite or sting

Thyroid eye disease (Graves orbitopathy)

Idiopathic orbital inflammatory syndrome (orbital pseudotumor)

Orbital tumors

Cavernous sinus / carotid-cavernous fistula

Subperiosteal hematoma

Mucocele of paranasal sinus

Erysipelas

Secondary Prevention, Discharge Plan, and Long-Term Management

— Preseptal cellulitis (outpatient): 7–10 days oral antibiotics; reassess at 48 hours

— Orbital cellulitis without abscess: IV until afebrile and clinically improved (typically 5–7 days), then oral to complete 2–3 weeks total

— With subperiosteal/orbital abscess: total 3–4 weeks

— With osteomyelitis or intracranial extension: 4–6+ weeks, often with OPAT (outpatient parenteral antibiotic therapy) via PICC line

— Oral step-down options: amoxicillin-clavulanate, clindamycin, linezolid, levofloxacin, TMP-SMX — guided by culture sensitivities

— Sinusitis: nasal saline irrigation, intranasal corticosteroid for 1–3 months, ENT follow-up; consider functional endoscopic sinus surgery for recurrent/chronic sinusitis

— Dental source: dental referral for extraction or root canal

— Dacryocystitis: dacryocystorhinostomy after resolution

— Recurrent disease: evaluate for immunodeficiency, nasal anatomic abnormalities, dental disease

— Hib, pneumococcal (PCV15/PCV20 + PPSV23), influenza, COVID-19

— In adults: pneumococcal vaccination per ACIP age-based schedule

— Optimize HbA1c <7% post-discharge to reduce recurrence and fungal risk

— Endocrinology referral if poorly controlled

— ID and possibly immunology follow-up

— Consider prophylactic measures (e.g., TMP-SMX for PJP in steroid users)

— Return precautions: fever, worsening pain, vision change, diplopia, severe headache

— Adherence importance — complete full antibiotic course

— Recognition of recurrence

Step 3 management: At discharge from orbital cellulitis admission, schedule ophthalmology follow-up within 1 week, ENT follow-up within 2 weeks (for sinus reassessment), and primary care within 1–2 weeks for medication reconciliation and vaccine update. Document the complete antibiotic stop date explicitly.

Antibiotic transition and total duration

Address the underlying source

Vaccinations to update at discharge

Smoking cessation — improves sinus mucociliary clearance and reduces recurrence

Diabetes management

Immunocompromised patients

Patient education

Follow-Up, Monitoring, and Counseling

— Visual acuity, pupillary exam, EOM, proptosis assessment q4h

— Vital signs q4h, daily weights

— CBC, CRP, BMP daily during IV antibiotics until trending down

— Vancomycin trough or AUC before 4th dose, then q3–5 days

— Cultures: blood, surgical material, sinus aspirate

— Repeat imaging if no improvement at 24–48 hours, worsening exam, or planning surgical drainage

— Afebrile ≥24 hours

— Clinical improvement in proptosis, EOM, vision

— Tolerating oral intake and oral antibiotics

— Pain controlled with oral analgesics

— Reliable follow-up arranged

— Preseptal outpatient: phone or in-person check at 48 hours; in-person at 7–10 days to confirm resolution

— Post-orbital cellulitis hospitalization:

— Ophthalmology: 1 week, then 1 month

— ENT: 2 weeks with nasal endoscopy

— Primary care: 1–2 weeks

— On OPAT: weekly CBC, BMP, drug levels; ID clinic q1–2 weeks

— Visual acuity, color vision, visual fields at each ophthalmology visit

— Strabismus or motility deficits — consider orthoptic evaluation

— Cosmetic concerns — oculoplastics referral

— Most patients with appropriate care recover full vision and function

— Recurrence risk especially with untreated chronic sinusitis or dental disease — address the source

— When to return immediately: vision change, severe headache, fever recurrence, diplopia, eye redness or pain

— In children: school return when afebrile and on oral antibiotics

— Ensure prescription affordability; some antibiotics (linezolid, posaconazole) are costly — coordinate with pharmacy for prior authorization

— Coordinate transitions of care with PCP via discharge summary including pending cultures and follow-up imaging

Board pearl: Failure to arrange explicit ophthalmology follow-up within 1 week after orbital cellulitis is a transitions-of-care safety lapse — recurrent or subclinical disease can lead to permanent vision loss. The discharge plan must name the follow-up provider, date, and time.

Inpatient monitoring parameters

Discharge readiness criteria

Outpatient follow-up schedule

Long-term sequelae screening

Counseling points

Health systems considerations

Ethical, Legal, and Patient Safety Considerations

— Lateral canthotomy and cantholysis in orbital compartment syndrome may be performed under implied/emergency consent when delay would cause irreversible vision loss; document the emergent indication clearly

— For elective abscess drainage or FESS, ensure full informed consent including risks of bleeding, CSF leak (FESS), visual loss, infection, scarring, and need for repeat procedures

— Parental/guardian consent required; assent from children ≥7 when developmentally appropriate

— In life- or sight-threatening emergencies with unavailable guardians, proceed under emergency exception and document

— Suspected child abuse when periocular injury history is inconsistent (e.g., orbital floor fracture in a non-ambulatory infant) — file CPS report; this is a legal obligation, not optional

— Elder abuse with similar inconsistencies in older patients

— Notifiable diseases: report invasive H. influenzae type b in unvaccinated children to public health

— Eye identification ("sign your site") prior to ocular procedures — wrong-eye surgery is a never event

— Time-out before lateral canthotomy or drainage

— Medication reconciliation at admission and discharge — high-yield for antibiotic interactions (warfarin + TMP-SMX, statin + macrolides)

— Vancomycin stewardship: appropriate indications, levels, and de-escalation prevent AKI and antimicrobial resistance

— Discharge summary must include: cultures pending, antibiotic stop date, follow-up appointments with names and dates, return precautions

— Closed-loop communication with PCP and specialists

— OPAT requires explicit lab monitoring schedule and line care education

— Counsel on Hib and pneumococcal vaccination of household contacts and children

— Address vaccine hesitancy with motivational interviewing; document refusal after counseling

— Uninsured patients may delay care leading to orbital extension — connect with social work, screen for food insecurity, housing, transportation that affect follow-up

— Language-concordant care or certified interpreters required for consent

Step 3 management: A 6-month-old presents with bilateral periorbital bruising and swelling; the parent's history is inconsistent. Even while treating presumed cellulitis, you must obtain skeletal survey, ophthalmology exam for retinal hemorrhages, and file a CPS report. Mandatory reporting is triggered by reasonable suspicion, not by proof.

Informed consent for procedures

Pediatric consent and assent

Mandatory reporting

Patient safety bundles

Transitions of care

Vaccination and public health duty

Health equity considerations

High-Yield Associations and Rapid-Fire Facts

— Orbital septum: fibrous extension of periosteum into eyelids — the boundary

— Ethmoid sinus = most common source of orbital cellulitis (thin lamina papyracea)

— Frontal sinus pneumatization begins age 5–6 → frontal-source orbital cellulitis rare before age 7

— Cavernous sinus contents: CN III, IV, V1, V2, VI and internal carotid artery — explains the multi-CN palsy pattern

— Preseptal in adults: S. aureus (incl. MRSA), S. pyogenes

— Orbital in children: S. aureus, Streptococcus species, H. influenzae (unvaccinated)

— Sinogenic with anaerobes: chronic sinusitis or dental source — Peptostreptococcus, Fusobacterium, Bacteroides

— Post-traumatic with soil: Clostridium, gram-negatives

— Aquatic exposure: Vibrio, Aeromonas

— Diabetic/DKA: Rhizopus (mucormycosis) — broad non-septate hyphae

— Neutropenic: Aspergillus, Pseudomonas

— CT: best for bone and sinus disease; rapid; first-line in orbital cellulitis

— MRI/MRV: best for cavernous sinus thrombosis, intracranial extension, fungal disease

— "Pain with eye movement" → orbital

— "Bilateral CN VI palsy with chemosis" → cavernous sinus thrombosis

— "Black eschar on turbinate in diabetic with DKA" → mucormycosis → emergent debridement + amphotericin

— "Forehead swelling over frontal sinus in adolescent" → Pott puffy tumor

— "S-shaped lid" → dacryoadenitis

— "Sulfur granules in canaliculus" → Actinomyces canaliculitis

— "Lid retraction, lag, bilateral proptosis, no fever" → Graves orbitopathy

— Empiric orbital: vancomycin + ceftriaxone (± metronidazole)

— Bedside emergency: lateral canthotomy + cantholysis for orbital compartment syndrome

— Cavernous sinus thrombosis: antibiotics + anticoagulation

Board pearl: If a question lists ethmoid sinusitis + proptosis + painful EOM in a school-age child, the answer is CT orbits with contrast + admit + IV vancomycin and ceftriaxone + ophthalmology and ENT consults — not topical antibiotics, not outpatient management, not MRI first.

Anatomy rapid recall

Microbiology associations

Chandler stages (memorize): I preseptal → II orbital cellulitis → III subperiosteal abscess → IV orbital abscess → V cavernous sinus thrombosis

Imaging pearls

Classic buzzwords

Treatment shortcuts

Board Question Stem Patterns

— 9-year-old boy with 4 days of URI now has unilateral eye swelling, pain with eye movement, fever 39°C, mild proptosis

— Next step: CT orbits and sinuses with contrast; IV vancomycin + ceftriaxone; admit

— Trap answer: oral amoxicillin-clavulanate as outpatient (insufficient for postseptal)

— Two near-identical vignettes; only difference is presence of pain with EOM or proptosis

— Choose the one that aligns with the exam finding

— Stem with bilateral eye findings, CN VI palsy, worsening despite IV antibiotics

— Next step: MRV brain; add anticoagulation; neurosurgery consult

— Diabetic in DKA with periorbital pain, black eschar on nasal turbinate, cranial nerve deficits

— Next step: ENT nasal endoscopy with biopsy, IV liposomal amphotericin B, urgent surgical debridement, correct DKA — NOT broad-spectrum antibacterials alone

— Trauma patient or post-surgical patient with sudden proptosis, IOP 50 mmHg, vision loss

— Next step: bedside lateral canthotomy and cantholysis before imaging

— Patient with orbital cellulitis on appropriate IV antibiotics for 48 hours with worsening exam

— Next step: repeat CT; surgical drainage by ENT/ophthalmology

— Bilateral painless proptosis, lid retraction, suppressed TSH

— Next step: TRAb level; smoking cessation; methimazole and ophthalmology referral — not antibiotics

— Unilateral painful proptosis with normal labs, no sinusitis, muscle enlargement including tendon on MRI

— Next step: high-dose corticosteroids (after infection excluded)

— 6-year-old with orbital cellulitis, small medial subperiosteal abscess (8 mm), preserved vision

— Next step: IV antibiotics with serial reassessment; defer surgery

— When can a patient with orbital cellulitis be discharged?

— Afebrile 24h, improved exam, tolerating PO; complete 2–3 weeks total antibiotics; ophthalmology follow-up in 1 week

Key distinction: When a stem says "vision change" or "pain with eye movement," the answer always involves CT, admission, IV antibiotics, and specialist consult — these phrases never lead to "discharge home on oral cephalexin."

Pattern 1 — Classic orbital cellulitis pediatric stem

Pattern 2 — Preseptal vs orbital discrimination

Pattern 3 — Cavernous sinus thrombosis

Pattern 4 — Mucormycosis

Pattern 5 — Lateral canthotomy stem

Pattern 6 — Failure of medical therapy

Pattern 7 — Graves mimic

Pattern 8 — Idiopathic orbital inflammation

Pattern 9 — Pediatric subperiosteal abscess

Pattern 10 — Discharge planning

One-Line Recap

The orbital septum separates preseptal cellulitis (treated as outpatient oral antibiotics if non-toxic, eye exam normal, and follow-up reliable) from orbital cellulitis (any pain with eye movement, proptosis, ophthalmoplegia, vision change, or chemosis), which mandates emergent contrast CT of the orbits and sinuses, IV vancomycin plus ceftriaxone, ophthalmology and ENT consultation, hospital admission, and serial visual acuity exams every four hours, with surgical drainage if there is a large abscess, vision compromise, or failure to improve within 24–48 hours.

Step 3 management: The single most testable decision point is recognizing that pain with eye movement or any visual change transforms a "swollen eyelid" into a vision- and life-threatening emergency requiring imaging, IV antibiotics, multidisciplinary consultation, and admission — never outpatient management.

The septum rules: anterior to septum = preseptal (outpatient possible); posterior = orbital (admit, IV, image).

Five postseptal red flags: proptosis, pain with EOM, ophthalmoplegia, decreased visual acuity, chemosis — any one triggers the full orbital protocol.

Empiric IV antibiotic combo: vancomycin (MRSA) + ceftriaxone (gram-positives/H. flu/CNS) ± metronidazole (anaerobes if dental or chronic sinus source) — covers Chandler I–IV.

Don't miss the catastrophes: cavernous sinus thrombosis (bilateral findings, multiple CN palsies — MRV + anticoagulation), mucormycosis (diabetic in DKA with black eschar — amphotericin B + emergent debridement), and orbital compartment syndrome (bedside lateral canthotomy and cantholysis for vision loss with IOP >40).